title: Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis.
abstract: Sepsis is a major cause of mortality and morbidity in trauma patients despite aggressive treatment. Traumatic injury may trigger infective or non-infective systemic inflammatory response syndrome (SIRS) and sepsis. Sepsis and SIRS are accompanied by an inability to regulate the inflammatory response but the cause of this perturbation is still unknown. The major pathophysiological characteristic of sepsis is the vascular collapse (i.e., loss of control of vascular tone); however, at the cellular level the final mediator of extreme vasodilatation has yet to be identified. After trauma, cellular injury releases endogenous damage-associated molecular patterns (DAMPs) that activate the innate immune system. Mitochondrial DAMPs express at least two molecular signatures, N-formyl peptides and mitochondrial DNA that act on formyl peptide receptors (FPRs) and Toll-like receptor 9, respectively. N-Formyl peptides are potent immunocyte activators and, once released in the circulation, they induce modulation of vascular tone by cellular mechanisms that are not completely understood. We have observed that N-formyl peptides from bacterial (FMLP) and mitochondrial (FMIT) sources induce FPR-mediated vasodilatation in resistance arteries. Accordingly, we propose that tissue and cellular trauma induces the release of N-formyl peptides from mitochondria triggering inflammation and vascular collapse via activation of FPR and contributing to the development of sepsis. The proposed hypothesis provides clinically significant information linking trauma, mitochondrial N-formyl peptides and inflammation to vascular collapse and sepsis. If our hypothesis is true, it may lead to new strategies in the management of sepsis that can help clinicians effectively manage non-infectious and infectious inflammatory responses.
authors.affiliation: Department of Physiology, Georgia Regents University, Augusta, GA, USA. Electronic address: camillawenceslau@hotmail.com.
authors.forename: C F
authors.initials: CF
authors.lastname: Wenceslau
authors.forename: C G
authors.initials: CG
authors.lastname: McCarthy
authors.forename: S
authors.initials: S
authors.lastname: Goulopoulou
authors.forename: T
authors.initials: T
authors.lastname: Szasz
authors.forename: E G
authors.initials: EG
authors.lastname: NeSmith
authors.forename: R C
authors.initials: RC
authors.lastname: Webb
mesh_terms: D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D024101:Mitochondrial Proteins / Q000378:metabolism*; D008954:Models, Biological; D044042:Receptors, Formyl Peptide / Q000378:metabolism; D018805:Sepsis / Q000209:etiology / Q000503:physiopathology*; D051217:Toll-Like Receptor 9 / Q000378:metabolism; D014652:Vascular Diseases / Q000209:etiology / Q000503:physiopathology*; D014664:Vasodilation / Q000502:physiology*; D014947:Wounds and Injuries / Q000150:complications* / Q000276:immunology
chemical_list: D024101:Mitochondrial Proteins; D044042:Receptors, Formyl Peptide; D051217:Toll-Like Receptor 9
references.citation: Crit Care Med. 2001 Jul;29(7):1303-10
references.pmid: 11445675
references.citation: Crit Care Med. 2001 Jul;29(7 Suppl):S109-16
references.pmid: 11445744
references.citation: Nat Med. 2003 May;9(5):517-24
references.pmid: 12724763
references.citation: Hippokratia. 2010 Apr;14(2):88-93
references.pmid: 20596262
references.citation: Cytokine Growth Factor Rev. 2001 Mar;12(1):91-105
references.pmid: 11312121
references.citation: Nature. 2002 Dec 19-26;420(6917):885-91
references.pmid: 12490963
references.citation: Eur J Immunol. 2005 Aug;35(8):2486-95
references.pmid: 16025565
references.citation: Adv Shock Res. 1981;6:27-36
references.pmid: 6760707
references.citation: Trends Immunol. 2002 Nov;23(11):541-8
references.pmid: 12401407
references.citation: Shock. 2010 May;33(5):473-8
references.pmid: 19749606
references.citation: J Theor Biol. 1967 Mar;14(3):255-74
references.pmid: 11541392
references.citation: J Pharmacol Exp Ther. 1989 Feb;248(2):774-80
references.pmid: 2537416
references.citation: J Orthop Trauma. 2010 Sep;24(9):534-8
references.pmid: 20736789
references.citation: Clin Sci (Lond). 2012 Oct;123(7):429-35
references.pmid: 22671429
references.citation: N Engl J Med. 2003 Jan 9;348(2):138-50
references.pmid: 12519925
references.citation: J Mol Cell Cardiol. 1997 Mar;29(3):881-94
references.pmid: 9152849
references.citation: Am J Pathol. 2007 May;170(5):1435-44
references.pmid: 17456750
references.citation: J Cell Sci. 2012 Feb 15;125(Pt 4):807-15
references.pmid: 22448037
references.citation: Am J Physiol. 1990 Mar;258(3 Pt 2):H848-53
references.pmid: 2107761
references.citation: Biochemistry. 1990 Dec 18;29(50):11123-33
references.pmid: 2176894
references.citation: Trends Immunol. 2011 Apr;32(4):157-64
references.pmid: 21334975
references.citation: J Exp Med. 1997 Dec 1;186(11):1831-41
references.pmid: 9382882
references.citation: Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):706-12
references.pmid: 7881660
references.citation: Klin Wochenschr. 1987 Jan 15;65(2):61-8
references.pmid: 3550266
references.citation: Cardiovasc Res. 2003 Oct 15;60(1):49-57
references.pmid: 14522406